Calcium and Sudden Cardiac Death in End-Stage Renal Disease

Seminars in Dialysis

Volumn 28, Issue 6, 2015, Pages 624-635

  Kim, Esther D ^a   Parekh, Rulan S ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ADVERSE EFFECTS; COMPLICATION; DEATH, SUDDEN, CARDIAC; HEALTH; HUMAN; INCIDENCE; KIDNEY FAILURE, CHRONIC; METABOLISM; RENAL REPLACEMENT THERAPY; RISK FACTOR; SURVIVAL RATE; VASCULAR CALCIFICATION;

CALCIUM; DEATH, SUDDEN, CARDIAC; GLOBAL HEALTH; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; RISK FACTORS; SURVIVAL RATE; VASCULAR CALCIFICATION;

EID: 84946481182     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12419     Document Type: Article

References (63)

1. System USRD: USRDS 2005 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2005
2. System USRD: USRDS 2006 Annual Data Report: Atlast of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2006
3. Bleyer AJ, Hartman J, Brannon PC, Reeves-Daniel A, Satko SG, Russell G: Characteristics of sudden death in hemodialysis patients. Kidney Int 69(12):2268-2273, 2006
4. Bleyer AJ: Prevention of sudden cardiac death in dialysis patients: a nephrologist's perspective. Dialysis & Transplantation. 37(4):124-129, 2008
5. Herzog CA: Cardiac arrest in dialysis patients: approaches to alter an abysmal outcome. Kidney Int Suppl 84:S197-S200, 2003
6. Foley RN: Clinical epidemiology of cardiac disease in dialysis patients: left ventricular hypertrophy, ischemic heart disease, and cardiac failure. Semin Dial 16(2):111-117, 2003
7. Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, etal.: The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: a 10year survey. Nephrol Dial Transplant 19(7):1829-1834, 2004
8. Huikuri HV, Castellanos A, Myerburg RJ: Sudden death due to cardiac arrhythmias. N Engl J Med 345(20):1473-1482, 2001
9. Parekh RS, Plantinga LC, Kao WH, Meoni LA, Jaar BG, Fink NE, etal.: The association of sudden cardiac death with inflammation and other traditional risk factors. Kidney Int 74(10):1335-1342, 2008
10. Pun PH, Lehrich RW, Honeycutt EF, Herzog CA, Middleton JP: Modifiable risk factors associated with sudden cardiac arrest within hemodialysis clinics. Kidney Int 79(2):218-227, 2011
11. Cardiovascolari GEEP: Multicentre, cross-sectional study of ventricular arrhythmias in chronically haemodialysed patients. Lancet 332(8606):305-309, 1988
12. Slinin Y, Foley RN, Collins AJ: Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16(6):1788-1793, 2005
13. Noordzij M, Korevaar JC, Boeschoten EW, Dekker FW, Bos WJ, Krediet RT, Netherlands Cooperative Study on the Adequacy of Dialysis Study G: The Kidney Disease Outcomes Quality Initiative (K/DOQI) Guideline for Bone Metabolism and Disease in CKD: association with mortality in dialysis patients. Am J Kidney Dis 46(5):925-932, 2005
14. London GM, Marty C, Marchais SJ, Guerin AP, Metivier F, de Vernejoul MC: Arterial calcifications and bone histomorphometry in end-stage renal disease. J Am Soc Nephrol 15(7):1943-1951, 2004
15. Saleh FN, Schirmer H, Sundsfjord J, Jorde R: Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 24(22):2054-2060, 2003
16. Movilli E, Feliciani A, Camerini C, Brunori G, Zubani R, Scolari F, etal.: A high calcium-phosphate product is associated with high C-reactive protein concentrations in hemodialysis patients. Nephron Clin Pract 101(4):c161-c167, 2005
17. Lowrie EG, Lew NL: Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15(5):458-482, 1990
18. Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, etal.: Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2(5):999-1007, 2007
19. Nordrehaug JE: Hypokalemia, arrhythmias and early prognosis in acute myocardial infarction. Acta Med. Scand. 217(3):299-306, 1985
20. Pun PH, Horton JR, Middleton JP: Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol 8(5):797-803, 2013
21. Schwartz PJ, Stramba-Badiale M, Segantini A, Austoni P, Bosi G, Giorgetti R, etal.: Prolongation of the QT interval and the sudden infant death syndrome. N Engl J Med 338(24):1709-1714, 1998
22. Algra A, Tijssen JG, Roelandt JR, Pool J, Lubsen J: QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest. Circulation 83(6):1888-1894, 1991
23. Priori SG, Bloise R, Crotti L: The long QT syndrome. Europace. 3(1):16-27, 2001
24. Clusin WT: Calcium and cardiac arrhythmias: DADs, EADs, and alternans. Crit Rev Clin Lab Sci 40(3):337-375, 2003
25. Bleyer AJ, Russell GB, Satko SG: Sudden and cardiac death rates in hemodialysis patients. Kidney Int 55(4):1553-1559, 1999
26. Cheung AK, Sarnak MJ, Yan G, Berkoben M, Heyka R, Kaufman A, etal.: Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int 65(6):2380-2389, 2004
27. Pun PH, Herzog CA, Middleton JP: Improving ascertainment of sudden cardiac death in patients with end stage renal disease. Clin J Am Soc Nephrol 7(1):116-122, 2012
28. Rose BD, Post TW: Clinical Physiology of Acid-Base and Electrolyte Disorders, 5th ed. USA: McGraw-Hill, 2001
29. Silverthorn DU, Ober WC, Garrison CW, Silverthorn AC, Johnson BR: Human Physiology: An Integrated Approach. San Francisco, CA: Pearson/Benjamin Cummings, 2009
30. Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, etal.: Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens 23(3):282-289, 2010
31. Chertow GM, Burke SK, Raggi P: Treat to Goal Working G. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62(1):245-252, 2002
32. Giachelli CM: The emerging role of phosphate in vascular calcification. Kidney Int 75(9):890-897, 2009
33. Russo D, Miranda I, Ruocco C, Battaglia Y, Buonanno E, Manzi S, etal.: The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 72(10):1255-1261, 2007
34. Yang H, Curinga G, Giachelli CM: Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization invitro. Kidney Int 66(6):2293-2299, 2004
35. Shroff RC, McNair R, Skepper JN, Figg N, Schurgers LJ, Deanfield J, etal.: Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 21(1):103-112, 2010
36. Chen NX, Kircelli F, O'Neill KD, Chen X, Moe SM: Verapamil inhibits calcification and matrix vesicle activity of bovine vascular smooth muscle cells. Kidney Int 77(5):436-442, 2010
37. Chen NX, O'Neill KD, Chen X, Duan D, Wang E, Sturek MS, etal.: Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins. Am J Physiol Renal Physiol 292(2):F599-F606, 2007
38. Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM: Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circ Res 109(6):697-711, 2011
39. Guerin AP, London GM, Marchais SJ, Metivier F: Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15(7):1014-1021, 2000
40. London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F, etal.: Aortic and large artery compliance in end-stage renal failure. Kidney Int 37(1):137-142, 1990
41. Mangrum AJ, Lin D, Dimarco JP, Bolton WK, Mangrum JM: Sudden cardiac death and left ventricular function in hemodialysis patients. Heart Rhythm 2(5):S33, 2005
42. Karnik JA, Young BS, Lew NL, Herget M, Dubinsky C, Lazarus JM, etal.: Cardiac arrest and sudden death in dialysis units. Kidney Int 60(1):350-357, 2001
43. Saran R, Bragg-Gresham JL, Levin NW, Twardowski ZJ, Wizemann V, Saito A, etal.: Longer treatment time and slower ultrafiltration in hemodialysis: associations with reduced mortality in the DOPPS. Kidney Int 69(7):1222-1228, 2006
44. Nappi SE, Virtanen VK, Saha HH, Mustonen JT, Pasternack AI: QTc dispersion increases during hemodialysis with low-calcium dialysate. Kidney Int 57(5):2117-2122, 2000
45. Covic A, Diaconita M, Gusbeth-Tatomir P, Covic M, Botezan A, Ungureanu G, etal.: Haemodialysis increases QT(c) interval but not QT(c) dispersion in ESRD patients without manifest cardiac disease. Nephrol Dial Transplant 17(12):2170-2177, 2002
46. Genovesi S, Dossi C, Vigano MR, Galbiati E, Prolo F, Stella A, etal.: Electrolyte concentration during haemodialysis and QT interval prolongation in uraemic patients. Europace. 10(6):771-777, 2008
47. RuDusky BM: ECG abnormalities associated with hypocalcemia. Chest 119(2):668-669, 2001
48. Donovan PJ, Propp DA: Calcium and its role in cardiac arrest: understanding the controversy. J Emerg Med 3(2):105-116, 1985
49. Barr CS, Naas A, Freeman M, Lang CC, Struthers AD: QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343(8893):327-329, 1994
50. Merx W, Yoon MS, Han J: The role of local disparity in conduction and recovery time on ventricular vulnerability to fibrillation. Am Heart J 94(5):603-610, 1977
51. Day CP, McComb JM, Campbell RW: QT dispersion: an indication of arrhythmia risk in patients with long QT intervals. Br Heart J 63(6):342-344, 1990
52. Saha H, Harmoinen A, Pietila K, Morsky P, Pasternack A: Measurement of serum ionized versus total levels of magnesium and calcium in hemodialysis patients. Clin Nephrol 46(5):326-331, 1996
53. Kimura K, Tabei K, Asano Y, Hosoda S: Cardiac arrhythmias in hemodialysis patients. A study of incidence and contributory factors. Nephron 53(3):201-207, 1989
54. Lam D, Kao WH, Sozio SM, Meoni LA, Shafi T, Jaar BG, etal.: Interdialytic ionized calcium is associated with a pro-arrhythmic phenotype in incident dialysis patients: the Predictors of Arrhythmic and Cardiovascular Risk in ESRD (PACE) Study [Abstract]. J Am Soc Nephrol 22:487A, 2011
55. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15(8):2208-2218, 2004
56. Clase CM, Norman GL, Beecroft ML, Churchill DN: Albumin-corrected calcium and ionized calcium in stable haemodialysis patients. Nephrol. Dial. Transplant. 15(11):1841-1846, 2000
57. Orrell DH: Albumin as an aid to the interpretation of serum calcium. Clin. Chim. Acta. 35(2):483-489, 1971
58. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, etal.: Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: a longitudinal study. Kidney Int 70(2):351-357, 2006
59. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, etal.: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70(4):771-780, 2006
60. Wald R, Sarnak MJ, Tighiouart H, Cheung AK, Levey AS, Eknoyan G, etal.: Disordered mineral metabolism in hemodialysis patients: an analysis of cumulative effects in the Hemodialysis (HEMO) Study. Am J Kidney Dis 52(3):531-540, 2008
61. Tentori F, Blayney MJ, Albert JM, Gillespie BW, Kerr PG, Bommer J, etal.: Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 52(3):519-530, 2008
62. Miller JE, Kovesdy CP, Norris KC, Mehrotra R, Nissenson AR, Kopple JD, etal.: Association of cumulatively low or high serum calcium levels with mortality in long-term hemodialysis patients. Am J Nephrol 32(5):403-413, 2010
63. Uhlig K, Berns JS, Kestenbaum B, Kumar R, Leonard MB, Martin KJ, etal.: KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD). Am J Kidney Dis 55(5):773-799, 2010